Ecoporc Shiga

1 x 50 ml

Suspension for injection

Active substance

E. coli (Stx2e antigen) (attenuated)

ATC code

QI09AB02 Escherichia

QI09AB Inactivated bacterial vaccines (including Mycoplasma, Toxoid and Chlamydia)

QI09A Immunologicals for pig

QI09 Immunologicals for suidae

QI Immunologicals

Species

Pigs

Indications

Active immunisation of piglets from the age of 4 days, to reduce the mortality and clinical signs of oedema disease caused by Stx2e toxin produced by E. coli (STEC).

Onset of immunity:	3 weeks after vaccination
Duration of immunity:	15 weeks after vaccination

Dose to be administered and administration route

Intramuscular use. The preferred application site is the neck muscle behind the ear. It is recommended to use a needle appropriate for the age of the piglets (preferred size 21G length 16 mm).

Prior to administration, shake the vaccine carefully.

A single intramuscular injection (1 ml) to pigs from the age of 4 days.

Adverse reactions

Pig:

Common

(1 to 10 animals / 100 animals treated):

Injection site swelling¹

Elevated temperature²

Uncommon

(1 to 10 animals / 1,000 animals treated):

Behavioural disorder ³

¹Small local reaction (maximum of 5 mm), subsiding within a short time (up to seven days) without treatment.

² A slight rise in body temperature (maximum of 1.7 °C), subsiding within a short time (maximum of two days) without treatment.

³ Temporary mild behavioural disturbances.

Reporting adverse events is important. It allows continuous safety monitoring of a veterinary medicinal product. Reports should be sent, preferably via a veterinarian, to either the marketing authorisation holder or the national competent authority via the national reporting system. See the package leaflet for respective contact details.